Aliqopa

Indicated For

relapsed follicular lymphoma

About This Medication

# Bayer US Patient Assistance Foundation Patient Guide: How to Get Aliqopa (copanlisib) at Low or No Cost Aliqopa (copanlisib) is a prescription medication used to treat certain types of cancer, and the **Bayer US Patient Assistance Foundation** helps eligible patients in the United States and Puerto Rico get it at no cost if they face financial challenges and meet specific criteria.[1][2][3][4] ## About Aliqopa (copanlisib) **Aliqopa (copanlisib)** is an intravenous kinase inhibitor developed by Bayer for adults with relapsed follicular lymphoma—a slow-growing type of non-Hodgkin lymphoma—who have received at least two prior treatments. It works by blocking specific enzymes (PI3K proteins) that cancer cells use to grow and survive, helping to slow disease progression. Administered by a healthcare professional every two weeks, it's not a cure but can extend remission periods for some patients. Common side effects include high blood sugar, low white blood cell counts, infections, fatigue, diarrhea, high blood pressure, nausea, and rash. Serious risks involve severe infections, lung problems, or stomach issues—always discuss with your doctor. This program focuses on financial access, not medical advice; consult your oncologist for treatment suitability.[1][3] ## Who Qualifies for the Program? The Bayer US Patient Assistance Foundation is a charitable organization aiding patients who: - Live in the **United States or Puerto Rico**. - Meet **certain income limits** (exact thresholds determined case-by-case; generally low-income households without other resources).[1][2][5] - Are **uninsured, underinsured**, or have government/commercial insurance where the drug isn't covered or affordable. - Have no alternative payment options and aren't solely applying due to insurer requirements.[1][5][7] **Key exclusions**: Patients eligible for other state/government aid must provide denial proof first. Medicare Part D Low-Income Subsidy (LIS/Extra Help) applicants (age 65+, income <150% FPL) need LIS denial documentation.[1][5] ## Income Eligibility Breakdown Specific dollar thresholds aren't publicly detailed, as eligibility is reviewed holistically by the Foundation. However, it's needs-based, targeting those below typical federal poverty guidelines (often <400-500% FPL, but confirm via application). Provide recent proof of all household income sources. | Household Size | Estimated Threshold (as % of FPL) | Notes | |---------------|----------------------------------|-------| | Individual | Case-by-case (<500% FPL likely) | Proof required: tax returns, pay stubs, etc.[1][2] | | Couple | Case-by-case | Include all household income.[2] | | Family of 3 | Case-by-case | No fixed numbers listed.[1] | | Family of 4+ | Case-by-case | Adjusted for dependents.[5] | **Tip**: Call (866) 228-7723 for pre-screening. Income is verified strictly—be accurate to avoid delays.[1][6] ## Insurance Requirements This program accepts: - **Uninsured** patients. - **Underinsured** (drug not covered or high costs). - **Government insurance** (e.g., Medicare Part D, but LIS-eligible need denial proof; coverage possible for calendar year).[1][5][7] - **Commercial/private** plans (unless insurer mandates PAP application without true need).[1] Medicare patients may qualify if not on Extra Help and medication isn't covered. Always exhaust other assistance first.[1][7] ## Step-by-Step Application Process 1. **Check Eligibility**: Review criteria online at patientassistance.bayer.us or call **(866) 228-7723** (Mon-Fri, 9AM-6PM ET). Note: (833) 254-7672 may be an alternate line.[1][5] 2. **Gather Documents**: - **Proof of residency** (e.g., utility bill, driver's license). - **Proof of income** (last year's tax return, W-2s, pay stubs, Social Security statements—for all household members). - **Prescription** from your doctor for Aliqopa. - Completed application (patient + HCP sections signed).[1][2] 3. **Complete the Form**: Download from patientassistance.bayer.us. Patient/caregiver fills pages 2-5; doctor completes page 6. Use checklist on page 7.[2] 4. **Submit**: - **Fax**: 1-866-575-6568 - **Mail**: Bayer US Patient Assistance Foundation, P.O. Box 5670, Louisville, KY 40255 - Online option possible via McKesson hub (ask rep).[1][2][5] 5. **Keep Copies**: Retain everything for your records.[2] **Pro Tip**: Incomplete apps are rejected—double-check![2] ## Timeline and Delivery Applications are **reviewed within 2 business days**, but incomplete ones take longer.[6] Approval grants free medication for **up to 1 year** (starts on acceptance date or Jan 1 for Medicare Part D).[5][7] **Reauthorization required** annually—resubmit before expiration.[7] Medication is **shipped directly to you** (or your pharmacy/HCP).[5] Expect 1-2 weeks total from submission to receipt if approved. Track status by calling.[6] ## Alternatives if Denied or Ineligible - **Appeal**: Contact the Foundation with additional docs (e.g., updated income proof).[1] - **Other Bayer Programs**: Check copay cards for commercially insured (not Medicare).[7] - **Government Aid**: Apply for Extra Help (1-800-MEDICARE), state programs, or 340B clinics. - **General Resources**: NeedyMeds.org, RxAssist.org, Partnership for Prescription Assistance, or cancer-specific orgs like Leukemia & Lymphoma Society. - **Manufacturer Copay**: If privately insured, explore Bayer's copay assistance (up to 100% coverage, annual cap).[7] - **Patient Access Network (PAN) Foundation** or HealthWell Foundation for lymphoma support. Shop around—many overlap. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. **Eligibility, rules, and availability can change**—always verify with Bayer at (866) 228-7723 or patientassistance.bayer.us. Not medical/financial advice. Consult your doctor for health decisions and a financial advisor for income planning. Bayer US Patient Assistance Foundation determines approval independently; denials aren't appealable beyond resubmission. Free meds don't affect Medicare coverage. Report changes in income/insurance immediately.[1][2][3] **Word count: 1028**

Program information last verified: March 30, 2026